|
|
Volumn 20, Issue 3, 2001, Pages 295-302
|
|
Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging
a
a
a
a
a
a
a
a
|
|
Author keywords
Cbfal; Myc; Oncogene collaboration; Retroviral tagging; Runt domain; Runx2
|
|
Indexed keywords
CARCINOGEN;
GENE PRODUCT;
PROTEIN P53;
TRANSCRIPTION FACTOR RUNX2;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
GENE FREQUENCY;
GENE OVEREXPRESSION;
GENE REARRANGEMENT;
GENE TARGETING;
GENETIC COMPLEMENTATION;
MOUSE;
NONHUMAN;
ONCOGENE C MYB;
ONCOGENE C MYC;
ONCOGENE MYC;
PHENOTYPE;
PRIORITY JOURNAL;
RETROVIRUS;
T CELL LYMPHOMA;
T LYMPHOCYTE;
TRANSGENIC MOUSE;
TUMOR GROWTH;
ANIMALS;
ANTIGENS, CD2;
ANTIGENS, CD3;
ATP-BINDING CASSETTE TRANSPORTERS;
CAENORHABDITIS ELEGANS PROTEINS;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
CORE BINDING FACTOR ALPHA 1 SUBUNIT;
CROSSES, GENETIC;
DNA-BINDING PROTEINS;
FUNGAL PROTEINS;
GENE REARRANGEMENT, T-LYMPHOCYTE;
GENETIC COMPLEMENTATION TEST;
HELMINTH PROTEINS;
HOMEODOMAIN PROTEINS;
LYMPHOMA, T-CELL;
MICE;
MICE, TRANSGENIC;
MOLONEY MURINE LEUKEMIA VIRUS;
NEOPLASM PROTEINS;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MYC;
PROTO-ONCOGENE PROTEINS C-PIM-1;
RETROVIRIDAE;
SACCHAROMYCES CEREVISIAE PROTEINS;
THYMUS NEOPLASMS;
TRANS-ACTIVATORS;
TRANSCRIPTION FACTORS;
TUMOR SUPPRESSOR PROTEIN P53;
ANIMALIA;
DROMAIUS NOVAEHOLLANDIAE;
LEUKAEMIA VIRUS;
MURINAE;
MUS MUSCULUS;
UNIDENTIFIED RETROVIRUS;
|
|
EID: 0035905751
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204090 Document Type: Article |
|
Times cited : (94)
|
|
References (50)
|
